納菲制藥
Nasal-Phyto
Categories Of News
Parkinson's New Drug! Inbrija, the first inhaled levodopa product, launched in the US to treat OFF s
Author：adminTime：2019/12/5 21:22:33Click：1994
March 4, 2019 / BIOON /-Biocor Therapeutics has announced the launch of Inbrija (levodopa inhalation powder) in the US market. The drug was approved by the US FDA on December 21, 2018 for use in Intermittent treatment for patients with Parkinson's di····
New drugs that benefit 340 million patients worldwide are expected to be declared for listing next y
Author：adminTime：2019/12/5 21:19:23Click：1811
Oyster Point Pharmaceuticals has submitted a NASDAQ listing application to the US Securities and Exchange Commission, and plans to raise $ 85 million in an IPO. This is a biotechnology company dedicated to developing first-in-class therapies for dry ····
The first new mechanism antidepressant in 30 years! Johnson & Johnson Spravato Nasal Spray Submits N
Author：adminTime：2019/12/5 21:15:38Click：1987
October 10, 2019 / Bio Valley BIOON /-Janssen Pharmaceuticals, a Johnson & Johnson subsidiary, recently announced that it has submitted a new supplement to the US Food and Drug Administration (FDA) depression drug Spravato (esketamine) CIII nasal spr····
New major depression drug launched! FDA approves new nasal spray formulation with rapid onset of act
Author：adminTime：2019/12/5 21:14:04Click：1993
On March 5, local time, the FDA issued a statement saying it agreed to approve the launch of a new nasal spray drug, Spravato (Esketamine), for the treatment of resistant depression. This is the first major depression treatment to enter the US market····
The first new medicine in 20 years! UCB's new epilepsy drug Nayzilam receives FDA approval
Author：adminTime：2019/11/28 9:52:07Click：1880
Belgian pharmaceutical company UCB recently announced that the US FDA has approved its latest antiepileptic drug (AED) Nayzilam (midazolam) nasal spray CIV. This is a benzodiazepine drug for nasal administration. It is suitable for the emergency trea····